ʻO nā paipu Laboratory

Huahana

ʻO Alprostadil 745-65-3 Hormone a me endocrine

ʻO ka wehewehe pōkole:

Nā huaʻōlelo like:Prostaglandin E1, PEG1

Helu CAS:745-65-3

ʻAno maikaʻi:USP43

ʻAno Molekala:C20H34O5

Kaumaha formula:354.48


Huahana Huahana

Huahana Huahana

Uku:T/T, L/C
Kumu Huahana:Kina
Awa moku:Pekina/Shanghai/Hangzhou
Hiki ke hana:1kg / mahina
Kauoha(MOQ): 1g
Ka manawa o waena o ka hoʻomaka a i ka wā pau:3 Nā lā hana
Kūlana mālama:me ka ʻeke hau no ka lawe ʻana, -20 ℃ no ka mālama lōʻihi
Mea paʻa:hue, ʻōmole
Nui pūʻolo:1g/puʻu, 5/puʻu, 10g/puʻu, 50g/puʻu, 500g/puʻu
ʻIke palekana:UN 2811 6.1/PG 3

Alprostadil

Hoʻolauna

ʻO Alprostadil, i kapa ʻia ʻo Prostaglandin E1 a i ʻole PEG1.Loaʻa ia i loko o ke kino o nā mea hana biologically, ʻoiai ʻo ia kekahi o ka ʻohana prostaglandin, he mea i ʻike ʻia e ka endogenous physiologically active substance.

Hiki ke hoʻohana pololei ʻia i ka ʻiʻo maʻemaʻe vascular, e hoʻonui i nā kīʻaha koko a hoʻonui i ke kahe o ke koko, hiki ke hoʻomaikaʻi i ka microcirculation perfusion.Hiki iā ia ke pale i ka platelet aggregation a me ka hana thromboxane A2, a me ka pale ʻana i ke atherosclerosis, lipid plaque a me ka hoʻokumu ʻana o ka paʻakikī.

Loaʻa iā ia nā hopena e pili ana: i ka hoʻonui ʻana i nā kīʻaha liʻiliʻi liʻiliʻi a me nā ʻaʻa coronary, ka hoʻemi ʻana i ke kūʻē ʻana o nā kīʻaha peripheral a me ke kahe koko.No ka pale ʻana i ka membrane platelet i hiki ke kū'ē i ka thrombosis.No ka pale ʻana i ka myocardium ischemic, hiki ke hōʻemi i ka nui o ka myocardial infarct.Hoʻohana ia no ka mālama ʻana i ka hōʻino anti-naʻau pū kekahi.Loaʻa iā ia ka hana diuretic a me ka pale ʻana i ka renal, e pili ana i ka hoʻonui ʻana i nā kīʻaha koko renal i mea e hoʻonui ai i ke kahe koko renal.Ma kēia ala, hiki iā ia ke wehe i ka nitrogen non-protein, a hoʻoponopono i ka sodium a me ka wai kaulike.

Hoʻohana nui ʻia ia ma ke kino.E like me ka pilikia o ka maʻi diabetic, ka maʻi naʻau coronary a me ka hiki ʻole o ka naʻau.Hoʻohana pū ʻia ma ke ʻano e like me ka maʻi naʻau congenital paʻakikī me ka hypertension pulmonary, cerebral infarction a me ka maʻi occlusive arterial maʻi.No kekahi mau hihia e like me ke kuli hikiwawe, retinal vein occlusion, viral hepatitis a i ʻole gastritis mau loa, he hana pū kekahi.Hiki iā ia ke hoʻohana i ka maʻi maʻi i nā maʻi ʻē aʻe e like me ka ʻeha duodenal, ka lawa ʻole o ka renal a me ka pancreatitis.Hoʻohana ia i ka hoʻololi ʻana i ke kino.Hoʻohana ʻia no nā maʻi ʻē aʻe e like me ka erectile dysfunction, induction hana a me ka hemorrhage postpartum, femoral head necrosis, lumbar disc herniation, postherpetic neuralgia a me bronchial asthma.

Pono e makaʻala i ka hoʻohana ʻana i nā maʻi i loaʻa i nā maʻi e like me ka puʻuwai puʻuwai, glaucoma, peptic ulcer a i ʻole interstitial pneumonia.Me ka hopena irritant i ka vein, e hōʻike i nā hōʻailona o ka mumū e like me ka ʻulaʻula, ka pehu, ka wela a me ka ʻeha, hiki ke kumu i ka phlebitis.Pono e ho'ōki i ka hoʻohana no ka palekana i ka wā e hiki mai ana ke kūlana.

Hōʻike (USP43)

'ikamu

Hōʻike

Ka nana aku Keʻokeʻo a melemele iki paha ka pauka crystalline
ʻIkepili IR
Ke koena ma ka ʻā ≤0.5%
Ka palena o ka chromium ≤0.002%
Ka palena o ka rhodium ≤0.002%
Nā mea pili Prostaglandin A1 ≤1.5%
Prostaglandin B1 ≤0.1%
ʻO kēlā me kēia haole prostaglandin haumia eluting ma mua o prostaglandin A1 ≤0.9%
ʻO ka haumia i ka manawa paʻa pili 0.6, pili i ka prostaglandin A1 ≤0.9%
ʻO ka huina o nā haumia i nā manawa paʻa pili 2.0 a me 2.3 ≤0.6%
ʻO nā mea ʻē aʻe prostaglandin haumia eluting ma hope o prostaglandin A1 ≤0.9%
Huina haumia ≤2.0%
Hoʻoholo wai ≤0.5%
Nā mea hoʻoheheʻe koena Ethanol ≤5000ppm
Acetone ≤5000ppm
Dichloromethane ≤600ppm
N-Hexane ≤290ppm
N-Heptane ≤5000ppm
Ethyl acetate ≤5000ppm
ʻIke (ma ke kumu anhydrous) 95.0%~105.0%

  • Mua:
  • Aʻe: